Paradigm Biocapital Advisors’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,203,308
Closed -$53.3M 38
2024
Q2
$53.3M Sell
1,203,308
-778,698
-39% -$35.9M 2.04% 17
2024
Q1
$111M Buy
1,982,006
+87,362
+5% +$5.27M 3.91% 8
2023
Q4
$114M Sell
1,894,644
-130,836
-6% -$8.29M 5.34% 5
2023
Q3
$136M Buy
2,025,480
+219,763
+12% +$15.3M 9.28% 1
2023
Q2
$125M Buy
1,805,717
+295,393
+20% +$19.3M 10.09% 1
2023
Q1
$72.8M Buy
1,510,324
+455,454
+43% +$22.3M 6.9% 3
2022
Q4
$52.7M Sell
1,054,870
-21,721
-2% -$1.05M 6.18% 5
2022
Q3
$43.9M Buy
1,076,591
+97,995
+10% +$4.6M 6.19% 5
2022
Q2
$53.8M Buy
978,596
+146,868
+18% +$6.2M 10.73% 1
2022
Q1
$30.2M Buy
831,728
+445,761
+115% +$17.6M 7.99% 4
2021
Q4
$18M Buy
+385,967
New +$19.6M 5.14% 8

Other funds holding LEGN